Research articlePossible involvement of the μ opioid receptor in the antinociception induced by Sinomenine (cas 115-53-7) on formalin-induced nociceptive behavior in mice

Add time:08/22/2019    Source:sciencedirect.com

Sinomenine (cas 115-53-7), an alkaloid originally isolated from the roots and the rhizome of Sinomenium acutum is used as a traditional Chinese herbal medicines for rheumatoid arthritis and neuralgia. The aims of this study were to investigate the effects of oral administration of shinomenine on formalin-induced nociceptive behavior in mice and the opioid receptor subtypes involved in the antinociceptive effects of sinomenine. Our findings showed that a single dose of oral-administrated sinomenine inhibited the formalin induced licking and biting responses in a dose-dependent manner. Intraperitoneal pretreatment with naloxone hydrochloride, an opioid receptor antagonist, and β-funaltrexamine hydrochloride (β-FNA), a selective μ-opioid receptor antagonist, significantly attenuated sinomenine induced antinociception, but not by naltrindole, a nonselective δ-opioid receptor antagonist and nor-binaltorphimine, a selective κ-opioid receptor antagonist. Furthermore, in western blot analysis, oral administration of sinomenine resulted in a significant blockage of spinal extracellular signal-regulated protein kinase (ERK1/2) activation induced by formalin. Naloxone hydrochloride and β-FNA significantly reversed the blockage of spinal ERK1/2 activation induced by sinomenine. These results suggest that sinomenine-induced anti nociceptive effect and blockage of spinal ERK1/2 activation may be triggered by activation of μ-opioid receptors.

We also recommend Trading Suppliers and Manufacturers of Sinomenine (cas 115-53-7). Pls Click Website Link as below: cas 115-53-7 suppliers

Prev:Resonance light-scattering spectroscopic determination of protein with Pyrocatechol Violet (cas 115-41-3)
Next:Sinomenine (cas 115-53-7) inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a)